Xiangxue Pharmaceutical: Announcement regarding the sale of subsidiary assets.
Xiangxue Pharmaceutical: “17 Pharmaceuticals 02” Bond Payment Exchange and Delisting Notice
Xiangxue Pharmaceutical: Interim Fiduciary Management Report on the Public Issuance of Corporate Bonds to Qualified Investors in 2017 (Phase II)
Xiangxue Pharmaceutical: Joint Credit Evaluation Co., Ltd.'s Notice of Concern on Matters Related to Guangzhou Xiangxue Pharmaceutical Co., Ltd. for the half year
Xiangxue Pharmaceutical: 2021 Fiduciary Management Report on Corporate Bonds
Xiangxue Pharmaceutical: Announcement on the tracking rating results of the public issuance of corporate bonds
Xiangxue Pharmaceutical: Guangzhou Xiangxue Pharmaceutical Co., Ltd. publicly issued corporate bonds 2022 tracking rating report
Xiangxue Pharmaceutical: 2021 Annual Report of Guangdong Yuecai Finance Guarantee Group Co., Ltd.
Xiangxue Pharmaceutical: Announcement that corporate bonds will be subject to investor appropriateness management
Xiangxue Pharmaceutical: Risk warning announcement on the possibility that corporate bonds may be subject to investor appropriateness management
Xiangxue Pharmaceutical: Announcement on Transfer of Limited Partnership Shares and Transfer of Shares by Subsidiaries
Xiangxue Pharmaceutical: Joint Credit Evaluation Co., Ltd.'s Notice of Concern on Guangzhou Xiangxue Pharmaceutical Co., Ltd.'s 2021 Annual Performance Forecast
Xiangxue Pharmaceutical: Announcement on Transfer of Subsidiaries' Shares and Change of Performance Commitment Plan
Xiangxue Pharmaceutical: Announcement on Transfer of Shares in Subsidiaries
Xiangxue Pharmaceutical: Announcement on Transfer of Shares in Subsidiaries
Xiangxue Pharmaceutical: “17 Pharma 02” bond interest payment announcement
Xiangxue Pharmaceutical: Announcement on Transfer of Shares in Subsidiaries
Xiangxue Pharmaceutical: Announcement on Transfer of Limited Partnership Shares
Xiangxue Pharmaceutical: Interim Fiduciary Management Report on the Public Issuance of Corporate Bonds to Qualified Investors in 2017 (Phase II)
Xiangxue Pharmaceutical: Annual Report of Corporate Bond Trustee Manager (2020)
No Data
No Data